The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Conjoined hyperactivation of the RAS and PI3K pathways in advanced GIST.
 
Bin Li
No Relationships to Disclose
 
Cesar Serrano Garcia
Speakers' Bureau - Novartis
Research Funding - Bayer
 
Adrian Marino-Enriquez
Travel, Accommodations, Expenses - Pfizer
 
Susanne Grunewald
No Relationships to Disclose
 
Yuexiang Wang
No Relationships to Disclose
 
Nacef Bahri
No Relationships to Disclose
 
Alexandra Lauria
No Relationships to Disclose
 
Chandrajit P. Raut
No Relationships to Disclose
 
Suzanne George
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie (I)
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Novartis; Pfizer
Research Funding - ARIAD (Inst); Bayer (Inst); Blueprint Medicines (Inst); Novartis (Inst); Pfizer (Inst)
 
George D. Demetri
Leadership - Blueprint Medicines
Stock and Other Ownership Interests - Bessor Pharma; Blueprint Medicines; Caris Life Sciences; Champions Oncology; G1 Therapeutics; Kolltan Pharmaceuticals
Consulting or Advisory Role - ARIAD; Bayer; Bessor Pharma; Blueprint Medicines; Caris Life Sciences; Champions Biotechnology; Daiichi Sankyo; EMD Serono; G1 Therapeutics; Genocea Biosciences; Janssen Oncology; Kolltan Pharmaceuticals; Kyocera; Lilly; Nektar; Novartis; Pfizer; PharmaMar; Polaris; Sanofi; WIRB-Copernicus Group
Research Funding - Bayer; Janssen Oncology; Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - Novartis
 
Jason L. Hornick
No Relationships to Disclose
 
Javier Martin Broto
Consulting or Advisory Role - Amgen; Bayer; GlaxoSmithKline; Novartis; PharmaMar
Speakers' Bureau - PharmaMar
Research Funding - GlaxoSmithKline; PharmaMar
Expert Testimony - Novartis; PharmaMar
Travel, Accommodations, Expenses - Pfizer; PharmaMar
 
Michael C. Heinrich
Stock and Other Ownership Interests - MolecularMD
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Blueprint Medicines; MolecularMD; Novartis; Pfizer
Research Funding - ARIAD (Inst); Arog (Inst); Deciphera (Inst); Inhibikase (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent on treatment of GIST-licensed to Novartis (Inst)
Expert Testimony - Novartis
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - Bayer; Blueprint Medicines; Lilly; Mundipharma
Travel, Accommodations, Expenses - Pharmamar
 
Christopher L. Corless
Consulting or Advisory Role - Cepheid; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Cepheid; Roche
 
Jonathan A. Fletcher
No Relationships to Disclose